Moreover, non-steroidal anti-inflammatory drugs (NSAIDs) and celecoxib, the selective COX-2, block CTNNB1-dependent transcription in CRC [176,177] and lessen polyp formation in FAP patients as well in in vivo mice models of colon cancer [178,179]. This evidence concerns the gene CTNNB1 and colorectal carcinoma.